title: Spectrophotometric determination of pipazethate HCl, dextromethorphan HBr and drotaverine HCl in their pharmaceutical preparations.
abstract: A simple, accurate and highly sensitive spectrophotometric method is proposed for the rapid determination of pipazethate hydrochloride, dextromethorphan hydrobromide and drotaverine hydrochloride using chromotrope 2B (C2B) and chromotrope 2R (C2R). The method consists of extracting the formed ion-associates into chloroform in the case of pipazethate HCl and dextromethorphan HBr or into methylene chloride in the case of drotaverine HCl. The ion-associates exhibit absorption maxima at 528, 540 and 532 nm with C2B and at 526, 517 and 522 nm with C2R for pipazethate HCl, dextromethorphan HBr and drotaverine HCl, respectively. The calibration curves resulting from the measurements of absorbance-concentration relations (at the optimum reaction conditions) of the extracted ion-pairs are linear over the concentration range 4.36-52.32 microg mL(-1) for pipazethate, 3.7-48.15 microg mL(-1) for dextromethorphan and 4.34-60.76 microg mL(-1) for drotaverine, respectively. The effect of acidity, reagent concentration, time, solvent and stoichiometric ratio of the ion-associates were estimated. The molar absorptivity and Sandell sensitivity of the reaction products were calculated. Statistical treatment of the results reflects that the procedure is precise, accurate and easily applied for the determination of the drugs under investigation in pure form and in their pharmaceutical preparations.
authors.affiliation: Chemistry Department, Faculty of Science, Benha University, Benha, Egypt.
authors.forename: Alaa S
authors.initials: AS
authors.lastname: Amin
authors.forename: Ragaa
authors.initials: R
authors.lastname: El-Sheikh
authors.forename: Faten
authors.initials: F
authors.lastname: Zahran
authors.forename: Ayman Abou El-fetouh
authors.initials: AA
authors.lastname: Gouda
mesh_terms: D000996:Antitussive Agents / Q000032:analysis* / Q000737:chemistry; D001581:Benzothiadiazines / Q000032:analysis* / Q000737:chemistry; D002138:Calibration; D002725:Chloroform / Q000737:chemistry; D003915:Dextromethorphan / Q000032:analysis* / Q000737:chemistry; D004305:Dose-Response Relationship, Drug; D008752:Methylene Chloride / Q000737:chemistry; D015394:Molecular Structure; D009282:Naphthalenesulfonates / Q000737:chemistry; D010208:Papaverine / Q000031:analogs & derivatives* / Q000032:analysis / Q000737:chemistry; D004364:Pharmaceutical Preparations / Q000032:analysis* / Q000737:chemistry; D012680:Sensitivity and Specificity; D012997:Solvents / Q000737:chemistry; D013056:Spectrophotometry, Ultraviolet; D013997:Time Factors; D014867:Water / Q000737:chemistry
chemical_list: D000996:Antitussive Agents; D001581:Benzothiadiazines; D009282:Naphthalenesulfonates; D004364:Pharmaceutical Preparations; D012997:Solvents; D014867:Water; C070620:chromotrope 2R; D008752:Methylene Chloride; D003915:Dextromethorphan; D002725:Chloroform; C005317:drotaverin; D010208:Papaverine; C016064:pipazethate